Mouse models of breast cancer in preclinical research

Breast Cancer remains the second leading cause of Cancer death among woman, worldwide, despite advances in identifying novel targeted therapies and the development of treating strategies. Classification of clinical subtypes (ER+, PR+, HER2+, and TNBC (Triple-negative)) increases the complexity of breast cancers, which thus necessitates further investigation. Mouse models used in breast Cancer research provide an essential approach to examine the mechanisms and genetic pathway in Cancer progression and metastasis and to develop and evaluate clinical therapeutics. In this review, we summarize tumor transplantation models and genetically engineered mouse models (GEMMs) of breast Cancer and their applications in the field of human breast Cancer research and anti-cancer drug development. These models may help to improve the knowledge of underlying mechanisms and genetic pathways, as well as creating approaches for modeling clinical tumor subtypes, and developing innovative Cancer therapy.

Breast cancer; genetically engineered mouse models; tumor transplantation model.